Tenaya Therapeutics, Inc. (TNYA) Tops Q2 EPS by 4c
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q2 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.
